Bahrain vs Saudi Arabia: Proportion of bloodstream infection due to methicillin-resistant
Bahrain
53.3%
in 2023
Saudi Arabia
49.5%
in 2023
Bahrain rank
10th
Saudi Arabia rank
13th
Proportion of bloodstream infection due to methicillin-resistant over time
- Bahrain
- Saudi Arabia
How they compare
Bahrain currently reports 53.3% against 49.5% in Saudi Arabia, a difference of 3.8%.
That makes Bahrain's figure about 1.1 times Saudi Arabia's.
The two have swapped places 1 time across 5 shared years of data; in 2018 it was Saudi Arabia ahead.
Bahrain ranks 10th and Saudi Arabia ranks 13th of 55 countries.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 37.8% | 47.7% | 10.0% | Saudi Arabia |
| 2020s | 43.3% | 50.2% | 6.9% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Bahrain or Saudi Arabia?
- Bahrain, at 53.3% against 49.5% in Saudi Arabia as of 2023.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Bahrain and Saudi Arabia?
- 3.8%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Saudi Arabia?
- 5 years are reported by both, from 2018 to 2023.
- How do Bahrain and Saudi Arabia rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Bahrain ranks 10th and Saudi Arabia ranks 13th of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.